Other

Novo Nordisk to buy RNA technology firm

Denmark's Novo Nordisk, the world's leading insulin maker, said Thursday it will buy US-based Dicerna Pharmaceuticals, a developer of RNA interference technology which targets genes that cause disease.

Health

Endocrine disrupters accelerate reproductive aging in rats

Female rats exposed to endocrine disrupters during early development end up with fewer eggs in their ovaries and are at risk of losing their ability to reproduce at an earlier age. These are some of the findings from a study ...

page 13 from 21